Anatomy, cause, activity and treatment response are separate questions. Preserve initial findings and work across specialties.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Build a diagnosis with the patient and other specialties
Uveitis assessment combines history, direct ocular examination and a systemic assessment, with selected investigations. Time spent with patients and families, careful reading, treatment planning and follow-up is part of the work. The original motivational remarks about fear, fascination, diagnostic satisfaction and catastrophic error are perspective; they do not establish the superiority of one specialty or an authenticated examiner role. 1
Ophthalmologists can directly document signs that may change after steroids; this supports their central role in ocular assessment. It does not justify delaying rheumatology, immunology, infection or renal assessment when needed. Document the first visit for subsequent clinicians rather than treating laboratory tests or other specialties as intrinsically inferior. 1
02Classify location, cause and course
Uveitis may be infectious, immune-mediated, idiopathic after an appropriate assessment, or a masquerade such as malignancy. The primary site defines anterior disease in the anterior chamber, intermediate disease in the vitreous, posterior disease in retina/choroid and panuveitis across these compartments. Iritis, iridocyclitis/anterior cyclitis and retinitis/choroiditis/chorioretinitis/retinochoroiditis/neuroretinitis describe related anatomical patterns. 1 2
Pars planitis is not a synonym for every idiopathic intermediate uveitis: it requires vitreous inflammation with snowballs or snowbanks and no associated infection or systemic disease. Anterior spillover cells do not alone make the vitreous the primary site. Record snowballs, snowbanking and pars-plana vascularisation separately, and evaluate their cause. 3 4
Describe onset as sudden or insidious and duration as limited (up to 3 months) or persistent (more than 3 months). Acute means sudden onset with limited duration; recurrent episodes are separated by at least 3 months of inactivity without treatment. Chronic disease is persistent and relapses promptly, within 3 months after treatment stops. Duration alone is not the entire course classification. 2
03Document signs before they change
Anterior disease may cause redness, light sensitivity, pain, altered vision and tearing; the original RSPV mnemonic helps explain symptoms but is not a diagnostic rule. Children with JIA may have a white, asymptomatic eye. Intermediate/posterior disease often causes floaters, photopsias and visual loss, and may show vascular sheathing, retinal/choroidal lesions, macular or disc oedema, optic-nerve involvement, neovascularisation or tractional, rhegmatogenous or exudative detachment. 1
Before dilation where feasible, document iris nodules, atrophy, pupil and cells so pigment release does not confuse the count. Use a dark room, bright narrow beam, oblique illumination and high magnification; the original at least 16× and 1–2 mm width are technique descriptions, while SUN cell grading uses a 1×1 mm field. Cells descend near the cooler cornea and rise near the iris. Record the technique for serial comparison. 1 2
SUN anterior cells are grade 0 below 1 cell, 0.5+ at 1–5, 1+ at 6–15, 2+ at 16–25, 3+ at 26–50 and 4+ above 50 cells in that field. Hypopyon is recorded separately, not automatically converted to cell grade 4+. Fibrin can obscure assessment and belongs in its own description; severe flare with fibrin is not the same scale as cell count. Vitreous haze is graded by disc and vessel visibility, separately from anterior cells. 2
04Use patterns as clues, not proof
Fine KPs suggest non-granulomatous and large mutton-fat KPs granulomatous inflammation; white versus pigmented/grey deposits and diffuse versus Arlt-triangle distribution help describe timing and morphology but do not identify an organism alone. Stellate diffuse KPs and iris atrophy suggest Fuchs; sectoral atrophy and pressure elevation raise HSV/VZV/CMV questions. Koeppe nodules are at the pupil margin and Busacca nodules on the iris stroma. KPs are aggregates of inflammatory cells including macrophages and lymphocytes. 1
A cold or shifting hypopyon can occur in Behçet disease but is not specific and does not exclude infection, malignancy or synechiae. An inverse pseudohypopyon may be floating silicone oil. Record blood, fibrin and anterior/posterior synechiae; one-sided disease suggests infection or HLA-B27 among other causes, while pressure rise can accompany herpes, Fuchs or Posner–Schlossman. Keratouveitis and sclerouveitis broaden the differential to infection and systemic vasculitis such as GPA/PAN. 1
Band keratopathy may accompany chronic JIA uveitis, sarcoidosis or other calcium/inflammation disorders. Extensive synechiae can occur in JIA, sarcoidosis and spondyloarthritis. Cotton-wool lesions are non-specific and can accompany SLE, HIV or other retinal disease; they do not alone establish CMV retinitis. Large granulomas raise sarcoid/TB questions. A quiet white eye does not exclude childhood inflammation. 1
05Ask focused questions and select investigations
Record age, symptoms and laterality, prior operations or trauma, medicines, autoimmune disease, travel/exposure and family history. Ask about skin/psoriasis, oral or genital ulcers, joints, lung, bowel and urinary symptoms. A structured questionnaire supports completeness. The original quoted psoriasis-family-history maxim is not a diagnostic rule: family history changes probability, not proof. Age and sex distributions may suggest Behçet or white-dot syndromes, but neither a male Behçet nor female white-dot stereotype establishes the diagnosis. 1
Hypothesis-driven tests reduce misleading incidental results, but laboratory or tissue evidence can be essential, not merely optional confirmation. Select syphilis treponemal/non-treponemal testing, TB skin/IGRA and chest assessment, or sarcoid ACE/lysozyme/chest imaging according to phenotype and risk; biopsy can establish systemic sarcoidosis when appropriate. Positive toxoplasma IgG or herpes serology alone does not diagnose ocular infection, and negative herpes serology is not a universal exclusion. The original ST mnemonic groups sarcoid, syphilis and TB questions; it does not mandate the same panel for everyone. 1
Selected aqueous or vitreous sampling can test suspected viruses, toxoplasma or TB, or investigate malignancy; PCR sensitivity, timing, prior treatment and sample handling matter. Clinical diagnoses such as VKH or sympathetic ophthalmia still require exclusion of plausible alternatives. Coordinate systemic investigations and urgent treatment rather than ordering every test indiscriminately. 1
06Separate inactivity, remission and the follow-up plan
Aim to control inflammation, preserve vision and minimise treatment toxicity; infection requires organism-directed care and some viral/toxoplasma diseases recur. SUN inactivity is grade 0 cells, not 0.5+. The original two-year steroid-free remission goal is a long-term treatment aspiration, not the SUN definition of remission, which requires inactivity for at least 3 months after stopping all treatment for eye disease. Steroid-free control while taking another immunomodulator is not identical to treatment-free remission. 1 2 5
Visits assess symptoms, cells, pressure, lens, posterior activity and OCT-detected macular oedema, alongside drug-specific blood count, liver/renal and other safety tests. The original fixed 6–8-week schedule even in remission is not universal; choose intervals for activity, disease, treatment changes and risk. Explain RSPV warnings and new floaters/photopsias or loss; a useful patient resource such as uveitis.org does not replace a personalised plan or verified primary evidence. 1
| Topic | Key concept | Clinical implication |
|---|---|---|
| Ophthalmic role | Direct ocular examination | Work with other specialties; no superiority rule |
| Anatomy | Anterior/intermediate/posterior/panuveitis | Primary site guides differential |
| Course | Recurrent after ≥3 months inactive off treatment; chronic relapse <3 months | Not duration alone |
| Cell grading | 0 to 4+ in 1×1 mm field | Hypopyon separately; not automatic 4+ |
| Diagnostic approach | History, ocular/systemic examination and selected tests | No indiscriminate panel; evidence may be essential |
| Examination | Bright narrow beam in dark room before dilation where feasible | Count inflammatory cells without pigment confusion |
| KPs | Fine versus mutton-fat; stellate suggests Fuchs | Morphology is a clue, not proof |
| Hypopyon | Cold/mobile can accompany Behçet | Exclude infection and other causes |
| Treatment goal | Original 2-year steroid-free aspiration | SUN remission ≥3 months inactive off all ocular treatment |
| Follow-up | Original 6–8-week example | Individual activity and toxicity monitoring |
What are the main learning points?
Anatomy, cause, activity and treatment response are separate questions. Preserve initial findings and work across specialties.
When is assessment urgent?
Rapid visual loss, severe pain, marked inflammation, a pressure rise or suspected infection/neurological disease needs urgent review, including a hypopyon when infection is possible.
References and access status
- 1Immutable original export; introductory lecture attributed to Baraa Al-Qubaisi / Syrian Ophthalmologists Initiative; attribution and quotations unverified
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2SUN first international workshop, 2005
Selected indexed original statements on course, cell grading and separate hypopyon recording read 15 November 2026; direct PMC access hit a browser challenge. No complete-source access claimed.
- 3SUN pars planitis classification criteria, 2021
Selected indexed introduction and classification Table 3 read 15 November 2026; full methods/test-performance study not appraised. Classification criteria do not replace individual diagnosis.
- 4DOG/BVA24a intermediate uveitis,14 June 2020
Selected actual indexed definition/differential text read 15 November 2026; not full 35 page guideline or a new 2026 version.
- 5Review 044/080/081: uveitis and source/monitoring boundaries
Historical source-ledger reuse; not a fresh appraisal of all underlying guidelines, infection tests or trials. Adult monitoring cannot be copied from JIA recommendations.
Original lecture link
For patients
Uveitis is inflammation inside the eye. Symptoms can recur, while some children have quiet-looking eyes despite inflammation; attend the planned examinations.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Rapid visual loss, severe pain, marked inflammation, a pressure rise or suspected infection/neurological disease needs urgent review, including a hypopyon when infection is possible.
Rapid visual loss, severe pain, marked inflammation, a pressure rise or suspected infection/neurological disease needs urgent review, including a hypopyon when infection is possible.